Search: onr:"swepub:oai:DiVA.org:uu-54322" >
Interference of ant...
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine
-
Frey, Sharon (author)
-
Dagan, Ron (author)
-
Ashur, Yaffa (author)
-
show more...
-
Chen, Xiao Q. (author)
-
Ibarra, Jose (author)
-
Kollaritsch, Herwig (author)
-
Mazur, Mark H. (author)
-
Poland, Gregory A. (author)
-
Reisinger, Keith (author)
-
Walter, Emmanuel (author)
-
Van Damme, Pierre (author)
-
Braconier, Mark M. (author)
-
- Uhnoo, Ingrid (author)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Friman, infektion
-
Wahl, Martin (author)
-
Blatter, Mark M. (author)
-
Clements, Dennis (author)
-
Greenberg, David (author)
-
Jacobson, Robert M. (author)
-
Norrby, S. Ragnar (author)
-
Rowe, Mina (author)
-
Shouval, Daniel (author)
-
Simmons, Sue S. (author)
-
van Hattum, Jan (author)
-
Wennerholm, Solveig (author)
-
Gress, Jacqueline O'Brien (author)
-
Chan, Ivan (author)
-
Kuter, Barbara (author)
-
show less...
-
(creator_code:org_t)
- Oxford University Press (OUP), 1999
- 1999
- English.
-
In: Journal of Infectious Diseases. - : Oxford University Press (OUP). - 0022-1899 .- 1537-6613. ; 180:6, s. 2018-2022
- Related links:
-
https://academic.oup...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- A randomized trial comparing 3 manufacturing consistency lots of a combination hepatitis A/hepatitis B vaccine to each other and to hepatitis A vaccine and hepatitis B vaccine given separately and concurrently was done to evaluate safety, tolerability, and immunogenicity. Healthy volunteers >/=11 years of age were divided into 4 groups. Each of 3 groups received a separate consistency lot of the combination vaccine, and 1 group received separate but concurrent injections of hepatitis A and hepatitis B vaccines. Injections were given at weeks 0 and 24. The combination vaccine was generally well tolerated. The hepatitis A portion of the combination vaccine produced clinically acceptable high seropositivity rates 4 and 52 weeks after the first injection. The hepatitis B portion of the vaccine did not produce clinically acceptable seropositivity rates 4 weeks after the second injection. Lack of antibody production may be attributed, at least in part, to immunologic interference.
Keyword
- MEDICINE
- MEDICIN
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Frey, Sharon
-
Dagan, Ron
-
Ashur, Yaffa
-
Chen, Xiao Q.
-
Ibarra, Jose
-
Kollaritsch, Her ...
-
show more...
-
Mazur, Mark H.
-
Poland, Gregory ...
-
Reisinger, Keith
-
Walter, Emmanuel
-
Van Damme, Pierr ...
-
Braconier, Mark ...
-
Uhnoo, Ingrid
-
Wahl, Martin
-
Blatter, Mark M.
-
Clements, Dennis
-
Greenberg, David
-
Jacobson, Robert ...
-
Norrby, S. Ragna ...
-
Rowe, Mina
-
Shouval, Daniel
-
Simmons, Sue S.
-
van Hattum, Jan
-
Wennerholm, Solv ...
-
Gress, Jacquelin ...
-
Chan, Ivan
-
Kuter, Barbara
-
show less...
- Articles in the publication
-
Journal of Infec ...
- By the university
-
Uppsala University